What is PrenatalSEQ?
PrenatalSEQ is a Non-invasive Prenatal Screening (NIPS) test that screens for chromosomal abnormalities in a developing fetus during pregnancy. PrenatalSEQ is available as early as 10 weeks gestation and requires just a single blood draw from the pregnant patient. Powered by Illumina’s CE-IVD VeriSeq™ NIPT Solution v2, PrenatalSEQ is performed in Genseq’s Dublin-based genomics laboratory. PrenatalSEQ is a screening test and must not be used as the sole basis for diagnosis or other pregnancy management decisions.